ITI Pharma & Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.62 %Nav, as on 29-09-2023

  • Previous Nav

  • Net Change on 29-09-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies engaged in Pharma and Healthcare.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 25.91 16.22 17.35 1.89 5,544.92
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 28.13 15.20 18.45 2.00 3,174.41
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 29.72 16.71 17.49 2.09 2,032.95
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 20.21 14.75 19.59 2.05 1,812.41
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 24.65 13.05 15.83 2.38 776.06

Fund Holdings as on 31-August-2023

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Dr. Reddy's Laboratories Limited

  • Max Healthcare Institute Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Suven Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • Alkem Laboratories Limited

  • Aurobindo Pharma Limited

  • Laurus Labs Limited

  • Mankind Pharma Limited

  • Syngene International Limited

  • Zydus Lifesciences Limited

  • Divi's Laboratories Limited

  • FDC Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Natco Pharma Limited

  • Vishnu Chemicals Limited

  • Gland Pharma Limited

  • Alembic Pharmaceuticals Limited

  • Astec LifeSciences Limited

  • Ajanta Pharma Limited

  • Net Receivables / (Payables)

  • Metropolis Healthcare Limited

  • Healthcare Global Enterprises Limited

  • Sanofi India Limited

  • Rainbow Childrens Medicare Limited

  • Abbott India Limited

  • Sun Pharma Advanced Research Company Limited

  • Ami Organics Limited

  • Fortis Healthcare Limited

  • Gujarat Fluorochemicals Limited

  • Vijaya Diagnostic Centre Limited

  • Sequent Scientific Limited

  • Dr. Lal Path Labs Limited

  • TTK Healthcare Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Pesticides & Agrochemicals

View More

  • Cash

  • Equity

View More

About ITI Pharma & Healthcare Fund

Scheme Analysis

ITI Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ITI Mutual Fund. It was launched on 08-Nov-2021 and currently has an AUM of ₹137.95 crore. ITI Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of ITI Pharma & Healthcare Fund ended up ₹0.18(1.62%)yesterday to ₹11.096.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The ITI Pharma & Healthcare Fund is managed by Dhimant Shah and Rohan Korde.

Fund House Contact

ITI House, 36, R K Shirodkar Marg, Parel Mumbai - 400 012

022-66214999
mfassist@itiorg.com
www.itiamc.com